Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-12-06

Clinical Trial Update: Study to Evaluate Efficacy and Safety of the Topical Product in Patients With Mild to Severe Scalp Psoriasis [Phase 3]

View source ↗

Summary

Phase 3 trial assessing efficacy and safety of a topical product for scalp psoriasis has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Topical product (unnamed in snippet)

Snippet

Sponsor: Sun Pharmaceutical Industries, Inc. | Conditions: Scalp Psoriasis | Phase 3 | Status: COMPLETED | Results posted: 2018-12-06